Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) and Gain Therapeutics (NASDAQ:GANX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Profitability This table compares KalVista Pharmaceuticals and […]
Acurx Pharmaceuticals (NASDAQ:ACXP – Get Free Report) and Gain Therapeutics (NASDAQ:GANX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 11.3% of Acurx […]
Gain Therapeutics, Inc Expected to Post Q1 2024 Earnings of ($0 46) Per Share (NASDAQ:GANX) kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Rating) – HC Wainwright lifted their Q4 2023 EPS estimates for Gain Therapeutics in a research report issued to clients and investors on Monday, May 15th. HC Wainwright analyst B. Pachaiyappan now anticipates that the company will earn ($0.28) per share for the quarter, up from their previous estimate […]